COVID-19 and thrombosis: repurposing old drugs and finding new targets

Australia has thankfully not had the level of exposure to COVID-19 as many other countries but our researchers will be in the mix in finding treatments to offset the thrombotic complications in severe COVID-19 disease. According to haematologist Dr James McFadyen, from the Atherothrombosis and Vascular Biology Program at the Baker Heart and Diabetes Institute, ...

Already a member?

Login to keep reading.

© 2021 the limbic